Live Breaking News & Updates on Clinician Scientist
Stay updated with breaking news from Clinician scientist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
the us presidentjoe biden will meet members of the asian american community in olathe after a deadly shooting there. in atlanta, georgia after a deadly shooting there. hello in a very warm welcome. a third wave of coronavirus is starting to sweep across the european union much of it driven by the uk variant. large parts of france are going into lockdown again tonight. switzerland is extending its restrictions. poland is going into partial lockdown. germans are being told not to travel at easter. the vaccine roll out across the eu has been slow with around just 10% of the population vaccinated so far. confidence has been shaken after a number of governments suspended the roll out of astrazeneca over concerns about blood clots. but vaccinations are restarting slowly as our paris correspondent lucy williamson reports. never mind the prime minister, in france, it was the astrazeneca jab that needed a shot in the arm today. after weeks of shifting guidelines, the message wa ....
Strengthening health systems through surgery medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
New study identifies mechanism of immune evasion of SARS-CoV-2 and variants medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin. ....